ELIOS Vision Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 47

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $188M

ELIOS Vision General Information

Description

Developer of eyecare technology intended to provide an effective treatment for glaucoma and lower eye pressure. The company's technology provides an implant-free, minimally invasive procedure that uses excimer laser light energy to create microscopic openings in the trabecular meshwork to re-establish the natural flow of eye fluid, or aqueous, enabling patients to lower intraocular pressure.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 555 South Flower Street
  • Suite 4400
  • Los Angeles, CA 90071
  • United States
Primary Industry
Surgical Devices
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Technology Systems
Other Healthcare Services
Parent Company
Corporate Office
  • 555 South Flower Street
  • Suite 4400
  • Los Angeles, CA 90071
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ELIOS Vision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 10-Dec-2024 $188M Completed Generating Revenue
1. Early Stage VC 07-Jul-2021 Completed Generating Revenue
To view ELIOS Vision’s complete valuation and funding history, request access »

ELIOS Vision Patents

ELIOS Vision Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240065893-A1 Systems and methods for a combined excimer laser and phacoemulsification unit Pending 30-Aug-2022
US-20240065892-A1 Systems and methods for treating patients with closed-angle or narrow-angle glaucoma using an excimer laser unit Active 30-Aug-2022
US-20240065894-A1 Systems and methods for prophylactic treatment of an eye using an excimer laser unit Active 30-Aug-2022
US-11918516-B1 Systems and methods for treating patients with closed-angle or narrow-angle glaucoma using an excimer laser unit Active 30-Aug-2022
US-11903876-B1 Systems and methods for prophylactic treatment of an eye using an excimer laser unit Active 30-Aug-2022 A61F9/00814
To view ELIOS Vision’s complete patent history, request access »

ELIOS Vision Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ELIOS Vision Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
ExSight Ventures Venture Capital Minority
To view ELIOS Vision’s complete investors history, request access »

ELIOS Vision FAQs

  • When was ELIOS Vision founded?

    ELIOS Vision was founded in 2019.

  • Where is ELIOS Vision headquartered?

    ELIOS Vision is headquartered in Los Angeles, CA.

  • What is the size of ELIOS Vision?

    ELIOS Vision has 47 total employees.

  • What industry is ELIOS Vision in?

    ELIOS Vision’s primary industry is Surgical Devices.

  • Is ELIOS Vision a private or public company?

    ELIOS Vision is a Private company.

  • What is the current valuation of ELIOS Vision?

    The current valuation of ELIOS Vision is .

  • What is ELIOS Vision’s current revenue?

    The current revenue for ELIOS Vision is .

  • Who are ELIOS Vision’s investors?

    ExSight Ventures has invested in ELIOS Vision.

  • When was ELIOS Vision acquired?

    ELIOS Vision was acquired on 10-Dec-2024.

  • Who acquired ELIOS Vision?

    ELIOS Vision was acquired by Bausch + Lomb.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »